Inducible nitric oxide synthase: From cloning to therapeutic applications

Ann Schwentker, Timothy R. Billiar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Elucidation of the many roles of nitric oxide (NO) in homeostasis and disease states has uncovered many areas where manipulation of NO production would be of therapeutic benefit. Recent advances in gene transfer technology and the cloning of the inducible nitric oxide synthase (iNOS) gene have led to the development of strategies for gene therapy to increase NO production for the treatment of disorders ranging from vascular restenosis to impaired wound healing. This review summarizes the current status of iNOS gene therapy research.

Original languageEnglish
Pages (from-to)772-778
Number of pages7
JournalWorld Journal of Surgery
Volume26
Issue number7
DOIs
StatePublished - Jul 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Inducible nitric oxide synthase: From cloning to therapeutic applications'. Together they form a unique fingerprint.

Cite this